Home > Boards > US OTC > Biotechs > Cytodyn Inc. (CYDY)

Thanks C-20, and for all you good stuff

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Hog Killer Member Profile
 
Followed By 4
Posts 299
Boards Moderated 0
Alias Born 10/05/20
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/27/2022 5:25:30 PM
Ousting of CytoDyn CEO Pourhassan boosts stock; shares up 12% Seeking Alpha - 1/26/2022 12:30:33 PM
CytoDyn announces change in leadership to support approval and commercialization of leronlimab Seeking Alpha - 1/25/2022 6:15:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/25/2022 5:02:41 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 1/10/2022 5:13:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/5/2022 5:16:52 PM
CytoDyn's leronlimab in 350 mg weekly dose met endpoints in Phase 2 NASH trial Seeking Alpha - 1/5/2022 9:38:39 AM
IQST - $0.60 Sleeper Stock Set To Explode In Fintech Parade Of Decacorn IPO's InvestorsHub NewsWire - 12/23/2021 11:51:16 AM
CytoDyn receives positive response from FDA for Phase 3 leronlimab study in COVID-19 Seeking Alpha - 12/21/2021 9:28:46 AM
CytoDyn files for expanded access use of leronlimab for HIV patients Seeking Alpha - 12/9/2021 9:13:36 AM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 11/30/2021 6:32:42 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 11/30/2021 6:32:41 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 11/30/2021 6:31:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/29/2021 6:30:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/29/2021 6:27:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/29/2021 6:20:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/24/2021 5:22:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/24/2021 4:05:01 PM
CytoDyn reports leronlimab data in NASH trial for first 15 patients Seeking Alpha - 11/24/2021 10:08:44 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/23/2021 5:24:15 PM
SA Breaking News - PURA estimates $1M in 2022 revenue InvestorsHub NewsWire - 11/22/2021 9:38:18 AM
PURA BULLISH RESURGANCE InvestorsHub NewsWire - 11/19/2021 8:50:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/17/2021 6:02:41 AM
CytoDyn submits the first section of HIV BLA to FDA under rolling review Seeking Alpha - 11/16/2021 7:07:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/9/2021 4:55:20 PM
Hog Killer   Tuesday, 04/06/21 01:13:33 PM
Re: C-20 post# 156972
Post # of 201826 
Thanks C-20, and for all you good stuff you post!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences